
General These Notes (as defined herein) are designed for an investor who seeks a fixed income investment at an interest rate of 5.60% per annumbut who is also willing to accept the risk that the Notes will be called, at our option, prior to the Maturity Date.At our option, we may redeem the Notes, in whole but not in part, on any of the Redemption Dates specified below.The Notes may be purchased in minimum denominations of $1,000 and in integral multiples of $1,000 thereafter. Key Terms Payment at Maturity: Call Feature: Subject to the Interest Accrual Convention, with respect to each Interest Period, for each $1,000 principal amountNote, we will pay you interest in arrears on each Interest Payment Date in accordance with the followingformula: Interest: $1,000 × Interest Rate × Day Count Fraction. The period beginning on and including the Original Issue Date and ending on but excluding the first InterestPayment Date, and each successive period beginning on and including an Interest Payment Date and ending onbut excluding the next succeeding Interest Payment Date, subject to any earlier redemption and the InterestAccrual Convention described below. Interest Payment Dates:Interest on the Notes will be payable in arrears on the 6thcalendar day of March of each year, beginning onMarch 6, 2027 to and including the Maturity Date (each, an “Interest Payment Date”), subject to any earlierredemption and the Business Day Convention and Interest Accrual Convention described below. Interest Rate:5.60% per annumPricing Date:March 5, 2026Original Issue Date:March 6, 2026 (Settlement Date)Maturity Date:March 6, 2046, subject to the Business Day Convention Business Day Convention:Following Interest AccrualConvention:UnadjustedDay Count Fraction:30/360CUSIP:91159XFK6 principal amount Note. See “Supplemental Plan of Distribution (Conflicts of Interest)” on page PS-7 of this pricingsupplement.(3)With respect to Notes sold to eligible institutional investors or fee-based advisory accounts for which an affiliated or principal amount Note. Broker-dealers who purchase the Notes for these accounts may forgo some or all sellingcommissions related to these sales. The per Note price to the public in the table above assumes a price to the public of$1,000 per $1,000 principal amount Note. Because our affiliate, USBI, is participating in sales of the Notes, the offering is being conducted in compliance with theapplicable requirements of Financial Industry Regulatory Authority (“FINRA”) Rule 5121. The Notes are unsecured obligations of U.S. Bancorp and all payments on the Notes are subject to the credit risk ofU.S. Bancorp. The Notes will not constitute deposits insured by the U.S. Federal Deposit Insurance Corporation or anyother government agency or instrumentality of the United States or any other jurisdiction.Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved ordisapproved of these Notes or determined if this pricing supplement or the accompanying prospectus supplement andprospectus is truthful or complete. Any representation to the contrary is a criminal offense.Investing in the Notes involves risks. See the “Additional Risk Factors” beginning on page PS-4 of this pricingsupplement and the “Risk Factors” beginning on page S-6 of the accompanying prospectus supplement.We will deliver the Notes in book-entry form through the facilities of DTC on or about March 6, 2026 against payment inimmediately available funds.U.S. Bancorp Investments, Inc. ABOUT THIS PRICING SUPPLEMENT You should read this pricing supplement together with the prospectus dated March 10, 2023 (the “prospectus”) and theprospectus supplement dated April 21, 2023 (the “prospectus supplement”), each relating to our Senior Medium-Term Notes, SeriesCC of which these Notes are a part, for additional information about the Notes. Information in this pricing supplement supersedesinformation in the prospectus supplement and the prospectus to the extent it is different from that information. Certain defined You should rely only on the information contained in or incorporated by reference in this pricing supplement and theaccompanying prospectus supplement and the prospectus. This pricing supplement may be used only for the purpose for which ithas been prepared. No one is authorized to give information other than that contained in this pricing supplement and theaccompanying prospectus supplement and the prospectus, and in the documents referred to in these documents and which are madeavailable to the public. We have not, and USBI has not, authorized any other person to provide you with different or additional We are not, and USBI is not, making an offer to sell the Notes in any jurisdiction where the offer or sale is not permitted. Youshould not assume that the information contained in or incorporated by reference in this pricing supplement or the accompanyingprospectus supplement or the prospectus i